HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084

By sjmartinez • October 29, 2024

Fogel JM, Persaud D, Piwowar-Manning E, Richardson P, Szewczyk J, Marzinke MA, Wang Z, Guo X, McCauley M, Farrior J, Tran HV, Ungsedhapand C, Mathew CA, Mpendo J, Rinehart AR, Rooney JF, Cohen MS, Hanscom B, Grinsztejn B, Hosseinipour MC, Delany-Moretlwe S, Landovitz RJ, Eshleman SH; HPTN 083 and HPTN 084 Study Teams. HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084. AIDS Res Hum Retroviruses. 2024 Oct 28. doi: 10.1089/aid.2024.0049. Epub ahead of print. PMID: 39466048.

Tags: Cabotegravir, DNA, HIV, HIV Prevention Trials Network, Infectious Diseases, Pre-exposure prophylaxis, prevention, Publications

T cell immune senescence is associated with frailty and sarcopenia in lung transplant candidates

Schaenman JM, Pickering H, Reed EF, Rossetti M, Seligman B, Weigt SS, Shino M, Sayah D, Belperio J, Hu A, Prosper A, Ruchalski K, Ardehali[...]

Misconceptions and limited experience with HIV pre-exposure prophylaxis (PrEP) among fishermen in Western Kenya: a qualitative study

Olugo P, Nishimura H, Thorp M, Lewis-Kulzer J, Ayieko B, Agot K, Kwena ZA, Camlin CS, Gutin SA. Misconceptions and limited experience with HIV pre-exposure[...]

Practical Steps to Advance Health Equity in Research from the UCLA COVID-19 Health Equity Research and Advisory Committee

Castillo EG, Guerrero AD, Bath EPJ, Dicker RA, Esrailian E, Hansen H, Harawa NT, Taira BR, Harris C. Practical Steps to Advance Health Equity in[...]